相关实验视频

Updated: Jul 30, 2026

A Novel In Vitro Live-imaging Assay of Astrocyte-mediated Phagocytosis Using pH Indicator-conjugated Synaptosomes

A Novel In Vitro Live-imaging Assay of Astrocyte-mediated Phagocytosis Using pH Indicator-conjugated Synaptosomes

Published on: February 5, 2018

来自天体细胞的CXCL10诱导神经高酸化和认知障碍在败血症中

Cuiping Guo^1,2,3, Hang Ruan¹, Wensheng Li³

¹Department of Emergency Medicine and Department of Critical Care Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.

Neuroscience bulletin

|July 2, 2025

概括

败血症相关的脑病包括大脑功能障碍和认知能力下降. 这项研究确定CXCL10是病理的关键驱动因素,并建议针对CXCL10-CXCR3通路获得治疗益处.

科学领域:

神经科学是一个神经科学.
免疫学免疫学免疫学
病理学病理学病理学

背景情况:

败血症相关脑病变 (SAE) 在败血症期间呈现为严重的神经功能障碍.
驱动SAE的确切机制,特别是神经炎症和病理,仍然不清楚.

研究的目的:

阐明神经炎症在SAE中的作用.
确定用于治疗败血症引起的认知障碍的分子标.

主要方法:

使用脂聚糖 (LPS) 诱导的败血症大鼠模型.
进行蛋白质和生物信息分析以确定关键的炎症媒介.
研究了CXCL10在体外和体外的影响,并阻止了CXCL10-CXCR3相互作用.

主要成果:

LPS诱导了陶过酸化,认知缺陷,神经炎症和海马中的质激活.
鉴定出CXCL10是一种中央调节剂,其由天体细胞分泌引发病理和突触缺陷.
阻止CXCL10-CXCR3信号传递改善了陶酸化,突触障碍和认知衰退.

结论:

CXCL10是败血症相关脑病变中病理的关键调解者.
CXCL10-CXCR3通路代表了与败血症相关的认知障碍的有前途的治疗标.

关键词:

在CXCL10/CXCR3中使用.卡姆基尔是什么意思卡姆基尔认知障碍认知障碍是一种认知障碍.败血症这是一种败血症.的酸化是的酸化.

更多相关视频

Visualizing Axonal Growth Cone Collapse and Early Amyloid β Effects in Cultured Mouse Neurons

Visualizing Axonal Growth Cone Collapse and Early Amyloid β Effects in Cultured Mouse Neurons

Published on: October 30, 2018

Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia

Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia

Published on: November 9, 2018

相关概念视频

Hepatic Encephalopathy

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...